ANI Pharmaceuticals, Inc. (ANIP) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 237.46M | 247.06M | 227.81M | 211.37M | 197.12M | 190.57M | 148.33M | 138.04M | 137.43M | 131.65M | 131.83M | 116.55M |
| Revenue Growth % | 20.46% | 29.64% | 53.58% | 53.12% | 43.43% | 44.75% | 12.52% | 18.44% | 28.7% | 39.71% | 57.27% | 57.81% |
| Cost of Goods Sold | 114.5M | 9.5M | 116.02M | 74.61M | 73.04M | 80.28M | 63.08M | 57.7M | 49.16M | 53.42M | 48.1M | 42.28M |
| COGS % of Revenue | 48.22% | 3.85% | 50.93% | 35.3% | 37.05% | 42.13% | 42.52% | 41.8% | 35.77% | 40.58% | 36.49% | 36.28% |
| Gross Profit | 122.96M | 237.56M | 111.79M | 136.76M | 124.08M | 110.29M | 85.26M | 80.34M | 88.27M | 78.23M | 83.73M | 74.26M |
| Gross Margin % | 51.78% | 96.15% | 49.07% | 64.7% | 62.95% | 57.87% | 57.48% | 58.2% | 64.23% | 59.42% | 63.51% | 63.72% |
| Gross Profit Growth % | -0.91% | 115.39% | 31.12% | 70.22% | 40.57% | 40.98% | 1.83% | 8.19% | 27.79% | 35.11% | 64.41% | 92.59% |
| Operating Expenses | 84.25M | 189.38M | 88.96M | 122.86M | 97.89M | 114.67M | 105.78M | 75.17M | 67.96M | 71.51M | 65.78M | 61.86M |
| OpEx % of Revenue | 35.48% | 76.66% | 39.05% | 58.13% | 49.66% | 60.17% | 71.31% | 54.46% | 49.45% | 54.32% | 49.9% | 53.08% |
| Selling, General & Admin | 73.66M | 82.79M | 76.66M | 81.77M | 76.53M | 69.72M | 79.08M | 52.82M | 48.02M | 44.46M | 42.01M | 38.76M |
| SG&A % of Revenue | 31.02% | 33.51% | 33.65% | 38.69% | 38.82% | 36.58% | 53.31% | 38.27% | 34.94% | 33.77% | 31.86% | 33.26% |
| Research & Development | 10.6M | 12.26M | 12.3M | 16.54M | 10.56M | 16.65M | 10.13M | 7.3M | 10.51M | 9.87M | 11.12M | 7.37M |
| R&D % of Revenue | 4.46% | 4.96% | 5.4% | 7.82% | 5.36% | 8.73% | 6.83% | 5.29% | 7.65% | 7.49% | 8.44% | 6.33% |
| Other Operating Expenses | 0 | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 38.71M | 48.17M | 22.83M | 13.89M | 26.19M | -4.38M | -20.52M | 5.17M | 20.31M | 6.73M | 17.95M | 12.4M |
| Operating Margin % | 16.3% | 19.5% | 10.02% | 6.57% | 13.29% | -2.3% | -13.83% | 3.74% | 14.78% | 5.11% | 13.61% | 10.64% |
| Operating Income Growth % | 47.77% | 1200.39% | 211.27% | 168.76% | 28.96% | -165.09% | -214.32% | -58.32% | 105.28% | 269.56% | 459.32% | 196.04% |
| EBITDA | 59.63M | 70.79M | 45.46M | 37.17M | 49.09M | 18.22M | -4.77M | 19.87M | 35M | 21.92M | 33.16M | 27.09M |
| EBITDA Margin % | 25.11% | 28.65% | 19.96% | 17.59% | 24.9% | 9.56% | -3.22% | 14.39% | 25.47% | 16.65% | 25.15% | 23.25% |
| EBITDA Growth % | 21.47% | 288.48% | 1052.92% | 87.12% | 40.25% | -16.87% | -114.39% | -26.67% | 42.3% | 26.04% | 220.18% | 2048.45% |
| D&A (Non-Cash Add-back) | 20.92M | 22.61M | 22.63M | 23.28M | 22.89M | 22.6M | 15.75M | 14.7M | 14.69M | 15.19M | 15.21M | 14.69M |
| EBIT | 38.71M | 54.32M | 38.53M | 15.96M | 25.47M | -7.75M | -29.17M | 2.37M | 29.93M | 6.69M | 17.91M | 12.35M |
| Net Interest Income | 3.77M | -17.43M | -4.73M | -5.44M | -5.48M | -6.01M | -2.33M | -4.66M | -4.6M | -5.75M | -6.4M | -7.1M |
| Interest Income | 0 | 5.41M | 0 | 2.78M | 2.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -3.77M | 22.84M | 4.73M | 8.22M | 8.11M | 6.01M | 2.33M | 4.66M | 4.6M | 5.75M | 6.4M | 7.1M |
| Other Income/Expense | 1.51M | -16.7M | 10.97M | -3.37M | -6.21M | -9.38M | -10.98M | -7.46M | 5.02M | -5.78M | -6.44M | -7.15M |
| Pretax Income | 40.22M | 31.48M | 33.8M | 10.53M | 19.99M | -13.76M | -31.5M | -2.29M | 25.34M | 947K | 11.51M | 5.25M |
| Pretax Margin % | 16.94% | 12.74% | 14.84% | 4.98% | 10.14% | -7.22% | -21.23% | -1.66% | 18.43% | 0.72% | 8.73% | 4.5% |
| Income Tax | 10.73M | 3.99M | 7.18M | 1.98M | 4.31M | -3.49M | -7.33M | 0 | 7.13M | -208K | 1.57M | -996K |
| Effective Tax Rate % | 26.68% | 12.67% | 21.25% | 18.77% | 21.54% | 25.33% | 23.28% | 0% | 28.13% | -21.96% | 13.65% | -18.98% |
| Net Income | 29.49M | 27.49M | 24.13M | 8.55M | 15.68M | -10.28M | -24.17M | -2.29M | 18.21M | 1.16M | 9.94M | 6.25M |
| Net Margin % | 12.42% | 11.13% | 10.59% | 4.04% | 7.95% | -5.39% | -16.29% | -1.66% | 13.25% | 0.88% | 7.54% | 5.36% |
| Net Income Growth % | 88.07% | 367.52% | 199.87% | 473.81% | -13.87% | -989.7% | -343.12% | -136.62% | 1165.25% | 127.22% | 215.58% | 141.85% |
| Net Income (Continuing) | 29.49M | 27.49M | 26.62M | 8.55M | 15.68M | -10.28M | -24.17M | -2.29M | 18.21M | 1.16M | 9.94M | 6.25M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.28 | 1.17 | 1.13 | 0.36 | 0.69 | -0.55 | -1.27 | -0.14 | 0.83 | 0.04 | 0.50 | 0.33 |
| EPS Growth % | 85.51% | 312.73% | 188.98% | 357.14% | -16.87% | -1510.26% | -354% | -142.42% | 1228% | 113.93% | 194.34% | 135.87% |
| EPS (Basic) | 1.31 | 1.24 | 1.19 | 0.37 | 0.70 | -0.55 | -1.27 | -0.14 | 0.84 | 0.04 | 0.50 | 0.33 |
| Diluted Shares Outstanding | 21.54M | 21.23M | 21.09M | 20.31M | 20.05M | 19.45M | 19.4M | 19.32M | 19.42M | 19.22M | 19.13M | 17.86M |
| Basic Shares Outstanding | 20.91M | 20.05M | 20.07M | 19.83M | 19.61M | 19.45M | 19.4M | 19.32M | 19.1M | 19M | 18.88M | 17.69M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |